Latest news

pathogenomix

Pathogenomix granted FDA Breakthrough Device Designation

PR Newswire | January 19, 2022

Star Tribune | December 23, 2021

EXCERPT: “We anticipate that we’ll have relationship with pretty much every company in Two Discovery Square,” said Dr. Clark Otley, medical director of the Department of Business Development at Mayo Clinic. 

Medical Design & Outsourcing | February 3, 2021